WO1999024589A3 - Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung - Google Patents

Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung Download PDF

Info

Publication number
WO1999024589A3
WO1999024589A3 PCT/DE1998/003287 DE9803287W WO9924589A3 WO 1999024589 A3 WO1999024589 A3 WO 1999024589A3 DE 9803287 W DE9803287 W DE 9803287W WO 9924589 A3 WO9924589 A3 WO 9924589A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
peptides
production
relates
lysozym
Prior art date
Application number
PCT/DE1998/003287
Other languages
English (en)
French (fr)
Other versions
WO1999024589B1 (de
WO1999024589A2 (de
Inventor
Klaus Duering
Original Assignee
Mpb Cologne Gmbh Molecular Pla
Klaus Duering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mpb Cologne Gmbh Molecular Pla, Klaus Duering filed Critical Mpb Cologne Gmbh Molecular Pla
Priority to NZ504368A priority Critical patent/NZ504368A/xx
Priority to JP2000520583A priority patent/JP2002503443A/ja
Priority to AU18679/99A priority patent/AU751422B2/en
Priority to IL13598798A priority patent/IL135987A0/xx
Priority to EP98963336A priority patent/EP1029061A2/de
Priority to CA002308618A priority patent/CA2308618A1/en
Publication of WO1999024589A2 publication Critical patent/WO1999024589A2/de
Publication of WO1999024589A3 publication Critical patent/WO1999024589A3/de
Publication of WO1999024589B1 publication Critical patent/WO1999024589B1/de
Priority to US09/567,563 priority patent/US6515106B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Die vorliegende Erfindung betrifft Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung. Diese Proteine oder Peptide sind entweder rekombinant oder durch Mutationen nur insoweit verändert, daß die wesentlichen, vor allem die antimikrobiellen Eigenschaften des T4 Lysozyms bis auf die Muramidase-Aktivität erhalten bleiben. Außerdem betrifft sie rekombinante Proteine, die mindestens die Aminosäuren 126-141 oder 143-155 des T4 Lysozyms enthalten. Die Erfindung schließt die Herstellung dieser Proteine oder Peptide aus ihren codierenden Genen über deren Biosynthese in pro- und eukaryontischen Organismen sowie über chemisch synthetisierte Proteine oder Peptide ein. Die erfindungsgemäße Verwendung dieser Proteine oder Peptide, die als medizinische Wirkstoffe, als Nahrungs- oder Futtermittelzusatzstoffe oder als andere antimikrobiell protektive Stoffe in vivo und in vitro oder als Fremdprotein in transgenen Organismen erfolgt, ist ebenfalls eingeschlossen.
PCT/DE1998/003287 1997-11-05 1998-10-31 Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung WO1999024589A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NZ504368A NZ504368A (en) 1997-11-05 1998-10-31 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
JP2000520583A JP2002503443A (ja) 1997-11-05 1998-10-31 抗微生物活性を持つリゾチーム類似タンパク質とペプチド、それらの生産および使用
AU18679/99A AU751422B2 (en) 1997-11-05 1998-10-31 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
IL13598798A IL135987A0 (en) 1997-11-05 1998-10-31 Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same
EP98963336A EP1029061A2 (de) 1997-11-05 1998-10-31 Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung
CA002308618A CA2308618A1 (en) 1997-11-05 1998-10-31 Lysozyme-analogous proteins and peptides with an anti-microbial effect, their production and use
US09/567,563 US6515106B1 (en) 1997-11-05 2000-05-05 Lysozyme-analogous polypeptides with an anti-microbial effect, their production and use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19749973.2 1997-11-05
DE19749973A DE19749973C1 (de) 1997-11-05 1997-11-05 Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/567,563 Continuation US6515106B1 (en) 1997-11-05 2000-05-05 Lysozyme-analogous polypeptides with an anti-microbial effect, their production and use

Publications (3)

Publication Number Publication Date
WO1999024589A2 WO1999024589A2 (de) 1999-05-20
WO1999024589A3 true WO1999024589A3 (de) 1999-11-04
WO1999024589B1 WO1999024589B1 (de) 2000-02-03

Family

ID=7848391

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1998/003287 WO1999024589A2 (de) 1997-11-05 1998-10-31 Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung

Country Status (9)

Country Link
US (1) US6515106B1 (de)
EP (1) EP1029061A2 (de)
JP (1) JP2002503443A (de)
AU (1) AU751422B2 (de)
CA (1) CA2308618A1 (de)
DE (1) DE19749973C1 (de)
IL (1) IL135987A0 (de)
NZ (1) NZ504368A (de)
WO (1) WO1999024589A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19749973C1 (de) * 1997-11-05 1998-10-22 Klaus Dr Duering Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung
ES2405848T3 (es) * 2003-12-23 2013-06-04 Biokit S.A. Composiciones y métodos para detección de infección patógena

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155190A2 (de) * 1984-03-16 1985-09-18 Genentech, Inc. Nicht in der Natur vorkommende Zymogene und Verfahren und Materialien zu deren Herstellung
EP0226158A2 (de) * 1985-12-11 1987-06-24 S P A SOCIETA' PRODOTTI ANTIBIOTICI S.p.a. Lysozymbetreffende Peptide
WO1989004371A1 (en) * 1987-11-02 1989-05-18 Louisiana State University Agricultural And Mechan Plants genetically enhanced for disease resistance
WO1990012866A1 (en) * 1989-04-10 1990-11-01 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
EP0412381A1 (de) * 1989-08-10 1991-02-13 Bayer Ag Verwendung von Lysozym gen-Konstruktionen in Pflanzen zur Resistenzerhöhung
WO1993005645A1 (en) * 1991-09-19 1993-04-01 Smart Plants International, Inc. Protection of plants against plant pathogens
WO1995018855A2 (en) * 1994-01-07 1995-07-13 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
DE19749973C1 (de) * 1997-11-05 1998-10-22 Klaus Dr Duering Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155190A2 (de) * 1984-03-16 1985-09-18 Genentech, Inc. Nicht in der Natur vorkommende Zymogene und Verfahren und Materialien zu deren Herstellung
EP0226158A2 (de) * 1985-12-11 1987-06-24 S P A SOCIETA' PRODOTTI ANTIBIOTICI S.p.a. Lysozymbetreffende Peptide
WO1989004371A1 (en) * 1987-11-02 1989-05-18 Louisiana State University Agricultural And Mechan Plants genetically enhanced for disease resistance
WO1990012866A1 (en) * 1989-04-10 1990-11-01 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
EP0412381A1 (de) * 1989-08-10 1991-02-13 Bayer Ag Verwendung von Lysozym gen-Konstruktionen in Pflanzen zur Resistenzerhöhung
WO1993005645A1 (en) * 1991-09-19 1993-04-01 Smart Plants International, Inc. Protection of plants against plant pathogens
WO1995018855A2 (en) * 1994-01-07 1995-07-13 Pioneer Hi-Bred International, Inc. Synthetic antimicrobial peptides
DE19749973C1 (de) * 1997-11-05 1998-10-22 Klaus Dr Duering Lysozym-analoge Proteine und Peptide mit antimikrobieller Wirkung, ihre Herstellung und ihre Verwendung

Non-Patent Citations (15)

* Cited by examiner, † Cited by third party
Title
ANAND, N., ET AL.: "Mutation of active site residues in synthetic T4-lysozyme gene and their effect on lytic activity", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 153, no. 2, 1988, pages 862 - 868, XP002102602 *
DESTEFANO-BELTRAN L ET AL: "ENHANCING BACTERIAL AND FUNGAL DISEASE RESISTANCE IN PLANTS: APPLICATION TO POTATO", MOLECULAR AND CELLULAR BIOLOGY OF THE POTATO, 1990, pages 205 - 221, XP002062296 *
DÜRING, K., ET AL.: "The non-enzymatic microbicidal activity of lysozymes", FEBS LETTERS, vol. 449, no. 2,3, 23 April 1999 (1999-04-23), pages 93 - 100, XP002113621 *
DÜRING, P., ET AL.: "Transgenic potato plants resistant to the phytopathogenic bacterium Erwinia carotovora", PLANT JOURNAL, vol. 3, no. 4, 1993, XP002102605 *
IBRAHIM, H., ET AL.: "Bactericidal action of lysozyme against Gram-negative bacteria due to insertion of a hydrophobic pentapeptide into its C-terminus", BIOSC. BIOTECH. BIOCHEM., vol. 56, no. 8, 1992, pages 1361 - 1363, XP002102640 *
IBRAHIM, H.R. ET AL.: "Antimicrobial effects of lysozyme against gram-negative bacteria due to covalent binding of palmitic acid", J. AGRIC. FOOD CHEM., vol. 39, 1991, pages 2077 - 2082, XP002102641 *
IBRAHIM, H.R., ET AL.: "Enhanced bactericidal action of lysozyme to Escherichia coli by inserting a hydrophobic pentapeptide into its C-terminus", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, 1994, pages 5059 - 5063, XP002102639 *
INOUYE, M., ET AL.: "The amino acid sequence of T4-phage lysozyme", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 245, 1970, pages 3479 - 3484, XP002113618 *
JAYNES J M ET AL: "EXPRESSION OF A CECROPIN B LYTIC PEPTIDE ANALOG IN TRANGENIC TABACCO CONFERS ENHANCE RESISTANCE TO BACTERIAL WILT CAUSED BY PSEUDOMONAS SOLANACEARUM", PLANT SCIENCE, vol. 89, 1993, pages 43 - 53, XP002049262, ISSN: 0168-9452 *
LINGXIU ZHONG ET AL: "DESIGN AND SYNTHESIS AMPHIPATHIC ANTIMICROBIAL PEPTIDES", INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, vol. 45, no. 4, 1 April 1995 (1995-04-01), pages 337 - 347, XP000493969 *
MCLEISH, M.J., ET AL.: "Conformation of a peptide corresponding to T4 lysozyme residues 59-81 by NMR and CD spectroscopy", BIOCHEMISTRY, vol. 33, 1994, pages 11174 - 11183, XP002113619 *
PELLEGRINI, A., ET AL.: "Bactericidal cativities of lysozyme and aprotinin against Gram-negative and Gram-positive bacteria related to their basic character", JOURNAL OF APPLIED BACTERIOLOGY, vol. 72, 1982, pages 180 - 187, XP002102604 *
PELLEGRINI, A., ET AL.: "Identification and isolation of a bactericidal domain in chicken egg white lysozyme", JOURNAL OF APPLIED MICROBIOLOGY, vol. 82, no. 3, March 1997 (1997-03-01), pages 372 - 378, XP002102603 *
RENNELL, D., ET AL.: "Systematic mutation of bacteriophage T4 lysozyme", J. MOL. BIOL., vol. 222, 1991, pages 67 - 87, XP002102601 *
WILD, P., ET AL.: "Reevaluation of the effect of lysozyme on Escherichia coli employing ultrarapid freezing followed by cryoelectronmicroscopy or freeze substitution", MICROSC RES TECH, vol. 39, no. 3, 1 November 1997 (1997-11-01), pages 297 - 304, XP002113620 *

Also Published As

Publication number Publication date
IL135987A0 (en) 2001-05-20
NZ504368A (en) 2002-11-26
AU1867999A (en) 1999-05-31
WO1999024589B1 (de) 2000-02-03
US6515106B1 (en) 2003-02-04
WO1999024589A2 (de) 1999-05-20
EP1029061A2 (de) 2000-08-23
JP2002503443A (ja) 2002-02-05
AU751422B2 (en) 2002-08-15
CA2308618A1 (en) 1999-05-20
DE19749973C1 (de) 1998-10-22

Similar Documents

Publication Publication Date Title
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
EP1283264A3 (de) Interleukin-3 (iL-3) mutanten Polypeptide
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
WO2007011975A3 (en) Methods to express recombinant proteins from lentiviral vectors
MXPA03002218A (es) Peptidos antimicrobianos y metodos de uso.
WO1996004373A3 (en) Recombinant production of biologically active peptides and proteins
JP2002535956A5 (de)
KR960704934A (ko) 항혈전활성을 갖는 펩티드 및 이의 제조방법(Peptide having antithrombotic activity and process for producing the same)
WO2002090553A3 (de) Rekombinante fusionsproteine und deren trimere
CA2249180A1 (en) Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
WO1997031116A3 (en) Recombinant ribonuclease proteins
WO2001005810A3 (de) CYCLISCHE PEPTIDDERIVATE ALS INHIBITOREN DES INTEGRINS αvβ¿6?
FR2766191B1 (fr) Peptides anti-microbiens de crustaces
WO2002070549A3 (en) Chimeric polypeptides of serum albumin and uses related thereto
Morin et al. Recombinant expression of indolicidin concatamers in Escherichia coli
WO1999024589A3 (de) Lysozym-analoge proteine und peptide mit antimikrobieller wirkung, ihre herstellung und ihre verwendung
WO2004033657A3 (en) Heat shock protein binding fragments of cd91, and uses thereof
CA2253006A1 (en) .beta.-carotene hydroxylase gene
WO2003057708A3 (en) Fusion proteins
EP0887410A3 (de) DNA kodierend für ein Plasminogen aktivierendes Protein
WO2001088114A3 (en) Gene expression system
WO2001030966A3 (en) An engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system
AP2002002509A0 (en) Recombinant oleosins from cacao and their use as flavoring or emulsifying agents.
WO2001005826A3 (en) Chimeric polypeptides of serum albumin and uses related thereto
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 135987

Country of ref document: IL

AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA IL JP NZ US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA IL JP NZ US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: B1

Designated state(s): AU CA IL JP NZ US

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

ENP Entry into the national phase

Ref document number: 2308618

Country of ref document: CA

Kind code of ref document: A

Ref document number: 2308618

WWE Wipo information: entry into national phase

Ref document number: 504368

Country of ref document: NZ

Ref document number: 09567563

Country of ref document: US

Ref document number: 18679/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1998963336

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998963336

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 18679/99

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1998963336

Country of ref document: EP